VENBIO GLOBAL STRATEGIC FUND IV, L.P.

Profile

Company Names

VENBIO GLOBAL STRATEGIC FUND IV, L.P.

Addresses

1700 OWENS STREET, SUITE 595, SAN FRANCISCO, CA 94158

Phone Numbers

415-522-0100

 

Entity Type:

LIMITED PARTNERSHIP

Industry:

VENTURE CAPITAL FUND

Year Incorporated:

2021

State Incorporated:

DELAWARE

Total Amount Raised:

$549,936,000.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2021-04-30 
$549,936,000.00 
$550,000,000.00 
$64,000.00 
 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ROBERT 
 
ADELMAN 
EXECUTIVE OFFICER
CERIMON PHARMACEUTICALS, INC.   |  VENBIO GLOBAL STRATEGIC FUND, L.P.   |  SIENTRA, INC.   |  ARAGON PHARMACEUTICALS, INC.   |  SOLSTICE BIOLOGICS LLC   |  LABRYS BIOLOGICS, INC.   |  VENBIO SELECT FUND LTD.   |  VENBIO SELECT FUND LLC   |  PRECISION BIOSCIENCES INC   |  METACRINE, INC.   |  APELLIS PHARMACEUTICALS, INC.   |  VENBIO GLOBAL STRATEGIC FUND II L.P.   |  TP THERAPEUTICS, INC.   |  VENBIO GLOBAL STRATEGIC FUND III, L.P.   |  VENBIO GLOBAL STRATEGIC FUND IV, L.P.
RICHARD 
 
GASTER 
EXECUTIVE OFFICER
ARRAKIS THERAPEUTICS, INC.   |  AEOVIAN PHARMACEUTICALS, INC.   |  STARGAZER PHARMACEUTICALS, INC.   |  ELEVATION ONCOLOGY, INC.   |  VENBIO GLOBAL STRATEGIC FUND IV, L.P.   |  ATTRALUS, INC.   |  VENTYX BIOSCIENCES, INC.   |  ALUMIS INC.   |  ENTACT BIO, INC.   |  VENBIO GLOBAL STRATEGIC FUND V, L.P.
COREY 
 
GOODMAN 
EXECUTIVE OFFICER
LIMERICK BIOPHARMA INC   |  IPIERIAN, INC.   |  VENBIO GLOBAL STRATEGIC FUND, L.P.   |  SECOND GENOME, INC.   |  MIRNA THERAPEUTICS, INC.   |  SOLSTICE BIOLOGICS LLC   |  LABRYS BIOLOGICS, INC.   |  VENBIO SELECT FUND LTD.   |  VENBIO SELECT FUND LLC   |  ALEXO THERAPEUTICS LTD   |  CHECKMATE PHARMACEUTICALS, INC.   |  VENBIO GLOBAL STRATEGIC FUND II L.P.   |  NFLECTION THERAPEUTICS, INC.   |  VENBIO GLOBAL STRATEGIC FUND III, L.P.   |  TALLAC THERAPEUTICS, INC.   |  VENBIO GLOBAL STRATEGIC FUND IV, L.P.   |  ATTRALUS, INC.   |  INSAMO INC.   |  VENBIO GLOBAL STRATEGIC FUND V, L.P.
DAVID 
 
PEZESHKI 
EXECUTIVE OFFICER
VENBIO GLOBAL STRATEGIC FUND III, L.P.   |  VENBIO GLOBAL STRATEGIC FUND IV, L.P.   |  VENBIO GLOBAL STRATEGIC FUND V, L.P.
AARON 
 
ROYSTON 
EXECUTIVE OFFICER
IMPEL NEUROPHARMA INC   |  MENLO THERAPEUTICS, INC.   |  HARMONY BIOSCIENCES II, INC.   |  AKERO THERAPEUTICS, INC.   |  VENBIO GLOBAL STRATEGIC FUND III, L.P.   |  SWIFT HEALTH SYSTEMS INC.   |  RAYZEBIO, INC.   |  VENBIO GLOBAL STRATEGIC FUND IV, L.P.   |  VENTYX BIOSCIENCES, INC.   |  NEUROGASTRX, INC.   |  MAREA THERAPEUTICS, INC.   |  VENBIO GLOBAL STRATEGIC FUND V, L.P.   |  ARPEGGIO BIOSCIENCES, INC.   |  CALDERA THERAPEUTICS, INC.
N/A 
 
VENBIO GLOBAL STRATEGIC GP IV, LLC 
PROMOTER
VENBIO GLOBAL STRATEGIC FUND IV, L.P.
N/A 
 
VENBIO MANAGEMENT COMPANY LLC 
EXECUTIVE OFFICER
VENBIO GLOBAL STRATEGIC FUND IV, L.P.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-05-14
D
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2021-04-30 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
BA SECURITIES LLC
153489
NONE
NONE
FAR HILLS GROUP, LLC
32243